338035 <common-name>N-[(e)-(5-bromo-2-methoxyphenyl)methylideneamino]-2-[[5-(4-bromophenyl)-4-phenyl-1,2,4-triazol-3-yl]sulfanyl]acetamide</common-name> <description>N-[(e)-(5-bromo-2-methoxyphenyl)methylideneamino]-2-[[5-(4-bromophenyl)-4-phenyl-1,2,4-triazol-3-yl]sulfanyl]acetamide is a chemical compound with the formula C24H19Br2N5O2S. With an average molecular weight of 601.30 g/mol, N-[(e)-(5-bromo-2-methoxyphenyl)methylideneamino]-2-[[5-(4-bromophenyl)-4-phenyl-1,2,4-triazol-3-yl]sulfanyl]acetamide is a heavy molecule.</description> <cas>303103-20-0</cas> <pubchem-id>9677566</pubchem-id> <chemical-formula>C24H19Br2N5O2S</chemical-formula> <weight>601.3</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-30T21:03:57Z</created-at> <updated-at type="dateTime">2026-08-30T21:03:57Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>COC1=C(C=C(C=C1)Br)C=NNC(=O)CSC2=NN=C(N2C3=CC=CC=C3)C4=CC=C(C=C4)Br</moldb-smiles> <moldb-formula>C24H19Br2N5O2S</moldb-formula> <moldb-inchi>InChI=1S/C24H19Br2N5O2S/c1-33-21-12-11-19(26)13-17(21)14-27-28-22(32)15-34-24-30-29-23(16-7-9-18(25)10-8-16)31(24)20-5-3-2-4-6-20/h2-14H,15H2,1H3,(H,28,32)/b27-14+</moldb-inchi> <moldb-inchikey>KHRIHAWZPUWGRN-MZJWZYIUSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">598.96262</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>5.9</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM333928</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>N-[(e)-(5-bromo-2-methoxyphenyl)methylideneamino]-2-[[5-(4-bromophenyl)-4-phenyl-1,2,4-triazol-3-yl]sulfanyl]acetamide</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Organoheterocyclic compounds</superklass> <klass>Azoles</klass> <subklass>Triazoles</subklass> <paper-count type="integer" nil="true"/> <sync-id>CED0288464</sync-id> <structure-inchikey>KHRIHAWZPUWGRN-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>4000200000800200000800000000000000000000400000000000400000000000000002000004008000002084000000000000000000000000200000000000000000000000000000000000000020400000000300000004800010000200000000010000000040000080100000800400080100000040000000000000000000006040000000800000000000000084880000010100000000000040000000000000000000000000000000080000000000000000400000000000002c00000080000000004000000000000100004000000000000000002000000200000000000000000040000000001048000000000400000000010020000040000000000000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAiAAAAJQAAAIABBgBgAAAAAQMIACgAAAAD AgZAKAAAAAMEBkAoAAAAAwQGQGgAAAADAwEGQCgAAAADBAZAaAAAAAMDAQZA aAAAAAMDASMAIAAAAAEGAGgAAAADAwEHACgAAAADAwcAaAAAAAMCAQYAKAAA AAMECAAoAAAAAwIGAGAAAAACAhAAIAAAAAIGQCgAAAADBAdAKAAAAAMDB0Ao AAAAAwMGQCgAAAADBAdAKAAAAAMDBkAoAAAAAwQGQGgAAAADAwEGQGgAAAAD AwEGQGgAAAADAwEGQGgAAAADAwEGQGgAAAADAwEGQCgAAAADBAZAaAAAAAMD AQZAaAAAAAMDAQZAKAAAAAMEBkBoAAAAAwMBBkBoAAAAAwMBIwAgAAAAAQsA AQABAiACA2gMAwRoDAQFaAwFBmgMBgdoDAUIAAMJIAkKKAIKCyALDCAMDSgC DA4ADg8ADxAAEBFoDBESaAwSE2gMExRoDBQVIBUWaAwWF2gMFxhoDBgZaAwZ GmgMExsgGxxoDBwdaAwdHmgMHh9oDB8gaAweIQAHAmgMFBBoDBoVaAwgG2gM QgQAAAAGAgcGBQQDBREQFBMSBhYXGBkaFQYcHR4fIBsXBAAAAAAAAAAW </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:38:55Z</structure-indexed-at> </compound>